“…In the words of McCullough et al, contrast nephropathy is predictable and presents an opportunity to utilize preventive strategies, given the increasing numbers of patients undergoing contrast procedures worldwide (5). In March-April, 2017, alone, in the Renal Unit, Mayo Clinic Health System, in northwestern Wisconsin, we had managed three patients who had developed AKI requiring hemodialysis in which contrast nephropathy played the major role, if not the sole role, for the observed nephrotoxicity (15). The resulting increased patient morbidity and potential patient mortality, the escalated healthcare costs and the social burden on families, of potentially preventable AKI requiring renal replacement therapy cannot be overemphasized (5,11,15).…”